These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 25820604)
1. The Development of a Communication Tool to Facilitate the Cancer Trial Recruitment Process and Increase Research Literacy among Underrepresented Populations. Torres S; de la Riva EE; Tom LS; Clayman ML; Taylor C; Dong X; Simon MA J Cancer Educ; 2015 Dec; 30(4):792-8. PubMed ID: 25820604 [TBL] [Abstract][Full Text] [Related]
2. Improving Research Literacy in Diverse Minority Populations with a Novel Communication Tool. Simon MA; Haring R; Rodriguez EM; González E; Kaur JS; Kirschner M; Tom L; O'Brian CA; Katz ML J Cancer Educ; 2019 Dec; 34(6):1120-1129. PubMed ID: 30144005 [TBL] [Abstract][Full Text] [Related]
3. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives. Langford AT; Hawley ST; Stableford S; Studts JL; Byrne MM J Cancer Educ; 2020 Jun; 35(3):454-461. PubMed ID: 30739270 [TBL] [Abstract][Full Text] [Related]
4. Underrepresentation of Hispanics and Other Minorities in Clinical Trials: Recruiters' Perspectives. Occa A; Morgan SE; Potter JE J Racial Ethn Health Disparities; 2018 Apr; 5(2):322-332. PubMed ID: 28452008 [TBL] [Abstract][Full Text] [Related]
5. A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking. Davis TC; Arnold CL; Mills G; Miele L Front Cell Dev Biol; 2019; 7():74. PubMed ID: 31114788 [TBL] [Abstract][Full Text] [Related]
6. Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Howerton MW; Gibbons MC; Baffi CR; Gary TL; Lai GY; Bolen S; Tilburt J; Tanpitukpongse TP; Wilson RF; Powe NR; Bass EB; Ford JG Cancer; 2007 Feb; 109(3):465-76. PubMed ID: 17200964 [TBL] [Abstract][Full Text] [Related]
7. Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). Haring RC; Henry WA; Hudson M; Rodriguez EM; Taualii M J Cancer Educ; 2018 Feb; 33(1):44-51. PubMed ID: 27392418 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. McIntyre J; Jiménez J; Rivera YM; Sutton SK; Asencio G; Castro-Figueroa EM; Gwede CK; Brandon TH; Vadaparampil ST; Simmons VN; Corchado J; Moreno L; Wells KJ; Quinn GP J Cancer Educ; 2018 Aug; 33(4):833-841. PubMed ID: 28378199 [TBL] [Abstract][Full Text] [Related]
9. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital. Joseph G; Dohan D Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887 [TBL] [Abstract][Full Text] [Related]
10. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Ford JG; Howerton MW; Lai GY; Gary TL; Bolen S; Gibbons MC; Tilburt J; Baffi C; Tanpitukpongse TP; Wilson RF; Powe NR; Bass EB Cancer; 2008 Jan; 112(2):228-42. PubMed ID: 18008363 [TBL] [Abstract][Full Text] [Related]
11. Biobanking in Israel 2016-17; expressed perceptions versus real life enrollment. Koren G; Beller D; Laifenfeld D; Grossman I; Shalev V BMC Med Ethics; 2017 Nov; 18(1):63. PubMed ID: 29149849 [TBL] [Abstract][Full Text] [Related]
12. A Case Study of Engaging Hard-to-Reach Participants in the Research Process: Community Advisors on Research Design and Strategies (CARDS)®. Kaiser BL; Thomas GR; Bowers BJ Res Nurs Health; 2017 Feb; 40(1):70-79. PubMed ID: 27686421 [TBL] [Abstract][Full Text] [Related]
13. Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach. Bolen S; Tilburt J; Baffi C; Gary TL; Powe N; Howerton M; Ford J; Lai G; Wilson R; Bass E Cancer; 2006 Mar; 106(6):1197-204. PubMed ID: 16453333 [TBL] [Abstract][Full Text] [Related]
14. Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials. Niranjan SJ; Durant RW; Wenzel JA; Cook ED; Fouad MN; Vickers SM; Konety BR; Rutland SB; Simoni ZR; Martin MY J Cancer Educ; 2019 Feb; 34(1):26-34. PubMed ID: 28776305 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Lai GY; Gary TL; Tilburt J; Bolen S; Baffi C; Wilson RF; Howerton MW; Gibbons MC; Tanpitukpongse TP; Powe NR; Bass EB; Ford JG Clin Trials; 2006; 3(2):133-41. PubMed ID: 16773955 [TBL] [Abstract][Full Text] [Related]
16. Involving South Asian patients in clinical trials. Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164 [TBL] [Abstract][Full Text] [Related]
17. Public Concern About Monitoring Twitter Users and Their Conversations to Recruit for Clinical Trials: Survey Study. Reuter K; Zhu Y; Angyan P; Le N; Merchant AA; Zimmer M J Med Internet Res; 2019 Oct; 21(10):e15455. PubMed ID: 31670698 [TBL] [Abstract][Full Text] [Related]
18. Clinical Trial and Research Study Recruiters' Verbal Communication Behaviors. Morgan SE; Mouton A; Occa A; Potter J J Health Commun; 2016 Jul; 21(7):765-72. PubMed ID: 27259754 [TBL] [Abstract][Full Text] [Related]
19. Needs, Priorities, and Recommendations for Engaging Underrepresented Populations in Clinical Research: A Community Perspective. Erves JC; Mayo-Gamble TL; Malin-Fair A; Boyer A; Joosten Y; Vaughn YC; Sherden L; Luther P; Miller S; Wilkins CH J Community Health; 2017 Jun; 42(3):472-480. PubMed ID: 27812847 [TBL] [Abstract][Full Text] [Related]
20. The project data sphere initiative: accelerating cancer research by sharing data. Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]